News

Home>News
News2020-07-17T11:41:26-04:00
Jul 72020

COVID-19 Cytokine Storm, Coronavirus’ Deadliest Stage – Halberd’s US Patent Pending Treatment Now Explained!

July 7th, 2020|Categories: Featured, News, Technology|Tags: , , , , , , |

Jackson Center, PA, July 7, 2020 – Halberd Corp. (OTC PINK: "HALB") today explains the second of three (3) COVID -19 (Coronavirus) patent pending treatments - “Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patients” - which was filed with the U.S. Patent and Trademark Office on April 8, 2020. Halberd Corporation holds the exclusive worldwide license to this technology To combat the patient’s overproduction of inflammatory ...

Jul 12020

Halberd Establishes UK Subsidiary

July 1st, 2020|Categories: Featured, News|Tags: , , |

Jackson Center, PA, July 1, 2020 – Halberd Corporation (OTC-PINK: "HALB") announced the establishment of a subsidiary in the United Kingdom to facilitate access to European research facilities and markets.  The subsidiary is Halberd Corporation UK, Ltd. William A. Hartman, Chairman, President & CEO of Halberd, stated, “This is the first step in our overall plan to expand our reach beyond North America and to establish a global footprint which is necessary given the breadth ...

Jun 292020

Halberd Method for Treating and Curing the COVID-19 Infection Explained

June 29th, 2020|Categories: Featured, News, Technology|Tags: , , , |

Jackson Center, PA, June 29, 2020 – Halberd Corporation (OTC-PINK: "HALB") today unveils the first of three (3) COVID -19 (Coronavirus) patent pending treatment methods -- the first titled, “Method for Treating and Curing Covid-19 Infection” -- filed with the U.S. Patent and Trademark Office on March 16, 2020.  Halberd holds exclusive worldwide license to this technology. The method applicable to any disease entails the extracorporeal (outside the body) treatment of a patient’s blood or ...

Jun 222020

NFL Retired Players Association’s Chief Medical Officer Joins Halberd Corporation to Lead COVID-19 Efforts

June 22nd, 2020|Categories: Featured, News, Technology|Tags: , , , |

Effective Immediately! Jackson Center, PA, June 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to the position of Chief Technical Officer effective immediately.  He will report to Halberd’s new Chairman, President and CEO, William A. Hartman and is currently the Chief Medical Officer of the NFL’s Retired Players Association (NFL RPA). Dr. Reyes will head up Halberd Corporation’s efforts in the development of a treatment to eradicate ...

Jun 152020

Halberd Designated “Pink Current Information” by OTC and Continues Technology Progress

June 15th, 2020|Categories: Featured, News, Technology|Tags: , , , , |

Jackson Center, PA, June 15, 2020 –Halberd Corporation (OTC Pink: HALB) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Corporation and now designates Halberd Corporation as "Pink Current Information". William A. Hartman, newly appointed Chairman, President and CEO explains, “Now that Halberd has been designated by OTC Markets as current in its filings and is now current with the Colorado Secretary of State, this completes the first ...

Jun 92020

Halberd Corporation Appoints Dr. Patricio Reyes to Scientific Advisory Board

June 9th, 2020|Categories: Featured, News, Technology|Tags: , , |

Jackson Center, PA, June 9, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately  He will report to Halberd’s Chairman, President and CEO, William A. Hartman. Dr. Reyes, MD, FAAN, a board certified neurologist and neuropathologist, is a Board Member of the Retired National Football League Players Association.  Dr. Reyes is a board member, and former Chair of the Education Committee and ...

Go to Top